ClinicalTrials.Veeva

Menu

Investigating Myocardial Remodelling in the Failing Human Heart (RELAX)

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Enrolling

Conditions

Heart Failure

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Despite improvements in therapy, heart failure is a disease with high mortality and accelerating prevalence. To improve patient care, it is necessary to better understand the features and underlying mechanisms of myocardial remodeling; how it manifests in vivo and its underlying cellular and extracellular changes. The RELAX study will offer insight into myocardial remodeling, by comprehensively assessing function and structure of failing human hearts, and investigate its underlying cellular and extracellular changes.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Eligible for heart transplantation
  • Willingness to participate in the present study and ability to understand and sign the written informed consent

Exclusion criteria

  • Patients under the age of 18.

Trial contacts and locations

1

Loading...

Central trial contact

Henrik Dukefoss, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems